Loading…
Memory improvement following induced hyperinsulinemia in alzheimer's disease
Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated w...
Saved in:
Published in: | Neurobiology of aging 1996, Vol.17 (1), p.123-130 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813 |
---|---|
cites | cdi_FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813 |
container_end_page | 130 |
container_issue | 1 |
container_start_page | 123 |
container_title | Neurobiology of aging |
container_volume | 17 |
creator | Craft, Suzanne Newcomer, John Kanne, Stephen Dagogo-Jack, Samuel Cryer, Philip Sheline, Yvette Luby, Joan Dagogo-Jack, Agbani Alderson, Amy |
description | Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated with a secondary elevation in plasma insulin levels, raising the question of whether improvement is due to changes in insulin levels, independent of hyperglycemia. Distributions of insulin receptors in the hippocampus and insulin-mediated increases in glucose utilization in entorhinal cortex provide potential mechanisms for such improvement. We show that raising plasma insulin through intravenous infusion while keeping plasma glucose at a fasting baseline level produces striking memory enhancement for patients with DAT. Previous findings of hyperglycemic memory enhancement were also replicated. Patients with DAT also showed abnormal plasma levels of glucoregulatory hormones and metabolites at baseline and during metabolic manipulations. Our findings suggest that neuroendocrine factors play an important role in the pathophysiology of DAT. |
doi_str_mv | 10.1016/0197-4580(95)02002-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78084464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0197458095020020</els_id><sourcerecordid>15616728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813</originalsourceid><addsrcrecordid>eNqFkMtuE0EQRVuIyDiBPyDSLBAhi4Gqdj83SMgCEskRG1i3enpqkkbzMN0eR87XM8aWl2RVi3vuVekw9hbhIwKqT4BWl0Ia-GDlNXAAXsILNkcpTYnC6pdsfkJesfOcfwOAFlrN2Mxoo7QVc7a6o25IuyJ26zRsqaN-UzRD2w6Psb8vYl-PgeriYbemFPs8trGnLvopKHz79ECxo3SVizpm8ples7PGt5neHO8F-_Xt68_lTbn68f12-WVVBmEWm1JiLa2scGG5hhp0HbAKwldKe7SVCgoRuOa88joIHRprZFNZaDhKC8Hg4oK9P-xOP_8ZKW9cF3OgtvU9DWN22oARQolnQZQKleZmAsUBDGnIOVHj1il2Pu0cgtvbdnuVbq_SWen-2XYw1S6P-2PVUX0qHfVO-btj7nPwbZN8H2I-YdwqY62asM8HjCZp20jJ5RCpn8zHRGHj6iH-_4-_GYGbCA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15616728</pqid></control><display><type>article</type><title>Memory improvement following induced hyperinsulinemia in alzheimer's disease</title><source>ScienceDirect Journals</source><creator>Craft, Suzanne ; Newcomer, John ; Kanne, Stephen ; Dagogo-Jack, Samuel ; Cryer, Philip ; Sheline, Yvette ; Luby, Joan ; Dagogo-Jack, Agbani ; Alderson, Amy</creator><creatorcontrib>Craft, Suzanne ; Newcomer, John ; Kanne, Stephen ; Dagogo-Jack, Samuel ; Cryer, Philip ; Sheline, Yvette ; Luby, Joan ; Dagogo-Jack, Agbani ; Alderson, Amy</creatorcontrib><description>Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated with a secondary elevation in plasma insulin levels, raising the question of whether improvement is due to changes in insulin levels, independent of hyperglycemia. Distributions of insulin receptors in the hippocampus and insulin-mediated increases in glucose utilization in entorhinal cortex provide potential mechanisms for such improvement. We show that raising plasma insulin through intravenous infusion while keeping plasma glucose at a fasting baseline level produces striking memory enhancement for patients with DAT. Previous findings of hyperglycemic memory enhancement were also replicated. Patients with DAT also showed abnormal plasma levels of glucoregulatory hormones and metabolites at baseline and during metabolic manipulations. Our findings suggest that neuroendocrine factors play an important role in the pathophysiology of DAT.</description><identifier>ISSN: 0197-4580</identifier><identifier>EISSN: 1558-1497</identifier><identifier>DOI: 10.1016/0197-4580(95)02002-0</identifier><identifier>PMID: 8786794</identifier><identifier>CODEN: NEAGDO</identifier><language>eng</language><publisher>London: Elsevier Inc</publisher><subject>Aged ; Alzheimer Disease - metabolism ; Alzheimer Disease - physiopathology ; Alzheimer Disease - psychology ; Alzheimer's disease ; Biological and medical sciences ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Fatty Acids - blood ; Glucagon - blood ; Humans ; Hyperglycemia - blood ; Hyperinsulinemia ; Hyperinsulinism - metabolism ; Lactates - blood ; Medical sciences ; Memory ; Memory - physiology ; Neurology ; Norepinephrine - blood ; Psychiatric Status Rating Scales</subject><ispartof>Neurobiology of aging, 1996, Vol.17 (1), p.123-130</ispartof><rights>1995</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813</citedby><cites>FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2968996$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8786794$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Craft, Suzanne</creatorcontrib><creatorcontrib>Newcomer, John</creatorcontrib><creatorcontrib>Kanne, Stephen</creatorcontrib><creatorcontrib>Dagogo-Jack, Samuel</creatorcontrib><creatorcontrib>Cryer, Philip</creatorcontrib><creatorcontrib>Sheline, Yvette</creatorcontrib><creatorcontrib>Luby, Joan</creatorcontrib><creatorcontrib>Dagogo-Jack, Agbani</creatorcontrib><creatorcontrib>Alderson, Amy</creatorcontrib><title>Memory improvement following induced hyperinsulinemia in alzheimer's disease</title><title>Neurobiology of aging</title><addtitle>Neurobiol Aging</addtitle><description>Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated with a secondary elevation in plasma insulin levels, raising the question of whether improvement is due to changes in insulin levels, independent of hyperglycemia. Distributions of insulin receptors in the hippocampus and insulin-mediated increases in glucose utilization in entorhinal cortex provide potential mechanisms for such improvement. We show that raising plasma insulin through intravenous infusion while keeping plasma glucose at a fasting baseline level produces striking memory enhancement for patients with DAT. Previous findings of hyperglycemic memory enhancement were also replicated. Patients with DAT also showed abnormal plasma levels of glucoregulatory hormones and metabolites at baseline and during metabolic manipulations. Our findings suggest that neuroendocrine factors play an important role in the pathophysiology of DAT.</description><subject>Aged</subject><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer Disease - physiopathology</subject><subject>Alzheimer Disease - psychology</subject><subject>Alzheimer's disease</subject><subject>Biological and medical sciences</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Fatty Acids - blood</subject><subject>Glucagon - blood</subject><subject>Humans</subject><subject>Hyperglycemia - blood</subject><subject>Hyperinsulinemia</subject><subject>Hyperinsulinism - metabolism</subject><subject>Lactates - blood</subject><subject>Medical sciences</subject><subject>Memory</subject><subject>Memory - physiology</subject><subject>Neurology</subject><subject>Norepinephrine - blood</subject><subject>Psychiatric Status Rating Scales</subject><issn>0197-4580</issn><issn>1558-1497</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkMtuE0EQRVuIyDiBPyDSLBAhi4Gqdj83SMgCEskRG1i3enpqkkbzMN0eR87XM8aWl2RVi3vuVekw9hbhIwKqT4BWl0Ia-GDlNXAAXsILNkcpTYnC6pdsfkJesfOcfwOAFlrN2Mxoo7QVc7a6o25IuyJ26zRsqaN-UzRD2w6Psb8vYl-PgeriYbemFPs8trGnLvopKHz79ECxo3SVizpm8ples7PGt5neHO8F-_Xt68_lTbn68f12-WVVBmEWm1JiLa2scGG5hhp0HbAKwldKe7SVCgoRuOa88joIHRprZFNZaDhKC8Hg4oK9P-xOP_8ZKW9cF3OgtvU9DWN22oARQolnQZQKleZmAsUBDGnIOVHj1il2Pu0cgtvbdnuVbq_SWen-2XYw1S6P-2PVUX0qHfVO-btj7nPwbZN8H2I-YdwqY62asM8HjCZp20jJ5RCpn8zHRGHj6iH-_4-_GYGbCA</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>Craft, Suzanne</creator><creator>Newcomer, John</creator><creator>Kanne, Stephen</creator><creator>Dagogo-Jack, Samuel</creator><creator>Cryer, Philip</creator><creator>Sheline, Yvette</creator><creator>Luby, Joan</creator><creator>Dagogo-Jack, Agbani</creator><creator>Alderson, Amy</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>Memory improvement following induced hyperinsulinemia in alzheimer's disease</title><author>Craft, Suzanne ; Newcomer, John ; Kanne, Stephen ; Dagogo-Jack, Samuel ; Cryer, Philip ; Sheline, Yvette ; Luby, Joan ; Dagogo-Jack, Agbani ; Alderson, Amy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Aged</topic><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer Disease - physiopathology</topic><topic>Alzheimer Disease - psychology</topic><topic>Alzheimer's disease</topic><topic>Biological and medical sciences</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Fatty Acids - blood</topic><topic>Glucagon - blood</topic><topic>Humans</topic><topic>Hyperglycemia - blood</topic><topic>Hyperinsulinemia</topic><topic>Hyperinsulinism - metabolism</topic><topic>Lactates - blood</topic><topic>Medical sciences</topic><topic>Memory</topic><topic>Memory - physiology</topic><topic>Neurology</topic><topic>Norepinephrine - blood</topic><topic>Psychiatric Status Rating Scales</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Craft, Suzanne</creatorcontrib><creatorcontrib>Newcomer, John</creatorcontrib><creatorcontrib>Kanne, Stephen</creatorcontrib><creatorcontrib>Dagogo-Jack, Samuel</creatorcontrib><creatorcontrib>Cryer, Philip</creatorcontrib><creatorcontrib>Sheline, Yvette</creatorcontrib><creatorcontrib>Luby, Joan</creatorcontrib><creatorcontrib>Dagogo-Jack, Agbani</creatorcontrib><creatorcontrib>Alderson, Amy</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neurobiology of aging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Craft, Suzanne</au><au>Newcomer, John</au><au>Kanne, Stephen</au><au>Dagogo-Jack, Samuel</au><au>Cryer, Philip</au><au>Sheline, Yvette</au><au>Luby, Joan</au><au>Dagogo-Jack, Agbani</au><au>Alderson, Amy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Memory improvement following induced hyperinsulinemia in alzheimer's disease</atitle><jtitle>Neurobiology of aging</jtitle><addtitle>Neurobiol Aging</addtitle><date>1996</date><risdate>1996</risdate><volume>17</volume><issue>1</issue><spage>123</spage><epage>130</epage><pages>123-130</pages><issn>0197-4580</issn><eissn>1558-1497</eissn><coden>NEAGDO</coden><abstract>Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated with a secondary elevation in plasma insulin levels, raising the question of whether improvement is due to changes in insulin levels, independent of hyperglycemia. Distributions of insulin receptors in the hippocampus and insulin-mediated increases in glucose utilization in entorhinal cortex provide potential mechanisms for such improvement. We show that raising plasma insulin through intravenous infusion while keeping plasma glucose at a fasting baseline level produces striking memory enhancement for patients with DAT. Previous findings of hyperglycemic memory enhancement were also replicated. Patients with DAT also showed abnormal plasma levels of glucoregulatory hormones and metabolites at baseline and during metabolic manipulations. Our findings suggest that neuroendocrine factors play an important role in the pathophysiology of DAT.</abstract><cop>London</cop><pub>Elsevier Inc</pub><pmid>8786794</pmid><doi>10.1016/0197-4580(95)02002-0</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0197-4580 |
ispartof | Neurobiology of aging, 1996, Vol.17 (1), p.123-130 |
issn | 0197-4580 1558-1497 |
language | eng |
recordid | cdi_proquest_miscellaneous_78084464 |
source | ScienceDirect Journals |
subjects | Aged Alzheimer Disease - metabolism Alzheimer Disease - physiopathology Alzheimer Disease - psychology Alzheimer's disease Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Fatty Acids - blood Glucagon - blood Humans Hyperglycemia - blood Hyperinsulinemia Hyperinsulinism - metabolism Lactates - blood Medical sciences Memory Memory - physiology Neurology Norepinephrine - blood Psychiatric Status Rating Scales |
title | Memory improvement following induced hyperinsulinemia in alzheimer's disease |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A36%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Memory%20improvement%20following%20induced%20hyperinsulinemia%20in%20alzheimer's%20disease&rft.jtitle=Neurobiology%20of%20aging&rft.au=Craft,%20Suzanne&rft.date=1996&rft.volume=17&rft.issue=1&rft.spage=123&rft.epage=130&rft.pages=123-130&rft.issn=0197-4580&rft.eissn=1558-1497&rft.coden=NEAGDO&rft_id=info:doi/10.1016/0197-4580(95)02002-0&rft_dat=%3Cproquest_cross%3E15616728%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c483t-51d595b139270d07dc1bc4ab67a19b6c61102722ba7c47cf985fb90f21590c813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15616728&rft_id=info:pmid/8786794&rfr_iscdi=true |